Genome-wide DNA methylation analysis of Romidpesin treated GCC cell lines

Illumina 450k DNA methylation microarray analysis of TCam-2, 2102EP, NCCIT and JAR cells 16 h after 10 nanomolar Romidepsin application. DMSO treated cells were used as controls. These data are part of the article 'The Histone Deacetylase Inhibitor Romidepsin is a Novel Therapeutic Option for (Cisplatin-resistant) Germ Cell Cancers' (Nettersheim et al., 2016). Genomic DNA was isolated by PCI extraction from TCam-2, 2102EP, NCCIT and JAR 16h after 10 nanomolar Romidepsin treatment. DMSO treated cells served as control.

本数据集针对经10纳摩尔罗米地辛（Romidepsin）处理16小时后的TCam-2、2102EP、NCCIT及JAR细胞开展Illumina 450k DNA甲基化微阵列分析。以二甲基亚砜（Dimethyl Sulfoxide，DMSO）处理的细胞作为对照。本数据集隶属于论文《组蛋白去乙酰化酶抑制剂罗米地辛是（顺铂耐药）生殖细胞癌的新型治疗选择》（Nettersheim等，2016年）。
基因组DNA通过PCI提取法，从经10纳摩尔罗米地辛处理16小时的TCam-2、2102EP、NCCIT及JAR细胞中分离得到，以DMSO处理的细胞作为对照。